Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Nucleic Acids Research
|
October 17, 2017
A cell-penetrating antibody inhibits human RAD51 via direct binding
Audrey Turchick, Denise C Hegan, Ryan B Jensen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 30, 2006
Triplex-stimulated intermolecular recombination at a single-copy genomic target
Melissa P Knauert, Jennifer M Kalish, Denise C Hegan, et al.
Oncotarget
|
February 14, 2018
Suppression of homology-dependent DNA double-strand break repair induces PARP inhibitor sensitivity in <i>VHL</i>-deficient human renal cell carcinoma
Susan E Scanlon, Denise C Hegan, Parker L Sulkowski, et al.
The Yale Journal of Biology and Medicine
|
December 19, 2013
Hypoxia and DNA repair
Peter M Glazer, Denise C Hegan, Yuhong Lu, et al.
Journal of the American Chemical Society
|
April 8, 2015
Mechanism of action studies of lomaiviticin A and the monomeric lomaiviticin aglycon. Selective and potent activity toward DNA double-strand break repair-deficient cell lines
Laureen C Colis, Denise C Hegan, Miho Kaneko, et al.
Carcinogenesis
|
May 5, 2017
Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells
Susan E Scanlon, Christine D Scanlon, Denise C Hegan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 11, 2011
Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate
Faye A Rogers, Sharon S Lin, Denise C Hegan, et al.
Nature Chemistry
|
May 23, 2014
The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA
Laureen C Colis, Christina M Woo, Denise C Hegan, et al.
Science Translational Medicine
|
October 27, 2012
Targeting cancer with a lupus autoantibody
James E Hansen, Grace Chan, Yanfeng Liu, et al.
Science Translational Medicine
|
February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Nucleic Acids Research
|
October 17, 2017
A cell-penetrating antibody inhibits human RAD51 via direct binding
Audrey Turchick, Denise C Hegan, Ryan B Jensen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 30, 2006
Triplex-stimulated intermolecular recombination at a single-copy genomic target
Melissa P Knauert, Jennifer M Kalish, Denise C Hegan, et al.
Oncotarget
|
February 14, 2018
Suppression of homology-dependent DNA double-strand break repair induces PARP inhibitor sensitivity in <i>VHL</i>-deficient human renal cell carcinoma
Susan E Scanlon, Denise C Hegan, Parker L Sulkowski, et al.
The Yale Journal of Biology and Medicine
|
December 19, 2013
Hypoxia and DNA repair
Peter M Glazer, Denise C Hegan, Yuhong Lu, et al.
Journal of the American Chemical Society
|
April 8, 2015
Mechanism of action studies of lomaiviticin A and the monomeric lomaiviticin aglycon. Selective and potent activity toward DNA double-strand break repair-deficient cell lines
Laureen C Colis, Denise C Hegan, Miho Kaneko, et al.
Carcinogenesis
|
May 5, 2017
Nickel induces transcriptional down-regulation of DNA repair pathways in tumorigenic and non-tumorigenic lung cells
Susan E Scanlon, Christine D Scanlon, Denise C Hegan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 11, 2011
Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate
Faye A Rogers, Sharon S Lin, Denise C Hegan, et al.
Nature Chemistry
|
May 23, 2014
The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA
Laureen C Colis, Christina M Woo, Denise C Hegan, et al.
Science Translational Medicine
|
October 27, 2012
Targeting cancer with a lupus autoantibody
James E Hansen, Grace Chan, Yanfeng Liu, et al.
Science Translational Medicine
|
February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
Page
of 1